ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

White House Agrees To Pay Raise For NCI, NIH, NHLI Chiefs

February 27, 1976

Declining Support Among Oncologists For Euthanasia.

October 13, 2000

US Oncology Inc. Asked For Drug Purchase Information.

July 4, 2003